ZEB2 and nasopharyngeal carcinoma: In this study, we identify circUBAP2(9,12) as a novel anti-tumor circRNA and reveal the circUBAP2(9,12)–AUF1–ZEB2 axis as a potential therapeutic vulnerability that may help address the challenge of NPC metastasis.